Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
BMJ Open|April 23, 2022
Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative studyGisele Chvetzoff, Magali Girodet, Johanna Despax, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Breast (Edinburgh, Scotland)|November 14, 2020
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA studyAnne-Claire Hardy-Bessard, Fabien Brocard, Florian Clatot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2024
Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA studyMathilde Lochmann, Magali Girodet, Johanna Despax, et al.
Bulletin Du Cancer|September 20, 2015
[Improving practice in breast pathology: 34-months experience of the regional SENOPATH network and webinars as a tool for diagnosis of difficult lesions of the breast]Marie-Laure Quintyn-Ranty, Karine Gordien, Paul Caveriviere, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2026
Integrated palliative care with early clinical trial: what oncologists say and what patients understandMathilde Lochmann, Magali Girodet, Johanna Despax, et al.
Bulletin Du Cancer|March 17, 2018
[Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey]Marianne Lorcet, Alain Lortholary, Jean Emmanuel Kurtz, et al.
Pageof 3